Lemaitre Vascular INC Form 4 insider transactions

Director David B. Roberts of Lemaitre Vascular, Inc. exercised stock options to acquire 2,818 shares of common stock at $35.48 per share on March 7, 2025.

Director Lawrence Jasinski sold 3,142 shares of Lemaitre Vascular (LMAT) at $92 per share on March 4, 2025.

Director Martha Shadan acquired 204 shares of LeMaitre Vascular common stock upon settlement of a Performance Share Unit (PSU) award and released dividend equivalent rights, as reported in a recent SEC Form 4 filing.

Director John A. Roush acquired 204 shares of LeMaitre Vascular common stock upon settlement of a Performance Share Unit (PSU) award on February 28, 2025.

Director Bridget A. Ross acquired shares of LeMaitre Vascular common stock following the settlement of a Performance Share Unit (PSU) award and the release of dividend equivalent rights.

Director John James O'Connor acquired 204 shares of LeMaitre Vascular (LMAT) common stock upon settlement of a Performance Share Unit (PSU) award and 1 share upon release of dividend equivalent rights on February 28, 2025.

Director Lawrence J. Jasinski acquired 204 shares of LeMaitre Vascular common stock on February 28, 2025, through the settlement of a Performance Share Unit (PSU) award.

Senior VP of Operations at LeMaitre Vascular, Trent G. Kamke, reports acquisition and disposal of common stock and dividend equivalent rights related to performance share units.

Joseph Pellegrino Jr., CFO of LeMaitre Vascular, reports acquisition and disposal of common stock and dividend equivalent rights related to performance share units.

Director David B. Roberts of LeMaitre Vascular, Inc. reports acquisition and disposal of common stock related to performance share unit (PSU) vesting and tax obligations.

George LeMaitre, Chairman and CEO of LeMaitre Vascular, reports transactions involving common stock related to performance share units and dividend equivalent rights.

Director David B Roberts acquired common stock and stock options in Lemaitre Vascular, Inc. on February 18, 2025.

George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, reports the acquisition and disposal of common stock and dividend equivalent rights.

David B. Roberts, President and Director of LeMaitre Vascular Inc., reports transactions involving common stock and dividend equivalent rights.

Joseph P. Pellegrino JR, CFO of LeMaitre Vascular, reports the acquisition and disposal of company stock related to dividend equivalent rights and tax withholding.

Trent G. Kamke, a Senior VP at Lemaitre Vascular Inc., reports the acquisition and disposal of company stock related to dividend equivalent rights and tax withholding obligations.

Director Lawrence J. Jasinski acquired shares of Lemaitre Vascular Inc. common stock through the vesting of dividend equivalent rights associated with restricted stock units and performance stock units.

David B. Roberts, President and Director of Lemaitre Vascular Inc., reported multiple transactions involving the acquisition and disposal of company stock and dividend equivalent rights.

LeMaitre Vascular's Chief Financial Officer, Joseph P. Pellegrino Jr., reported multiple transactions involving the acquisition and disposal of company stock and dividend equivalent rights following the vesting of restricted stock units and performance stock units.

Director John James O'Connor acquired shares of Lemaitre Vascular Inc. through the vesting of dividend equivalent rights associated with restricted stock units and performance stock units.

Director Bridget A. Ross acquired shares of LeMaitre Vascular Inc. through the vesting of dividend equivalent rights associated with restricted stock units and performance stock units.

Director John A. Roush acquired shares of Lemaitre Vascular Inc. through the release of dividend equivalent rights associated with vesting restricted stock units and performance stock units.

LeMaitre Vascular's CEO, George W. LeMaitre, reported the acquisition of shares through the vesting of stock units and the subsequent withholding of shares to cover tax obligations.

Director Martha Shadan acquired shares of Lemaitre Vascular Inc. through the release of dividend equivalent rights associated with previously granted stock awards.

Senior VP of Operations at Lemaitre Vascular, Trent G. Kamke, reports stock transactions related to the vesting of restricted stock units and performance stock units.

Director Martha Shadan acquired 1,725 shares of Lemaitre Vascular common stock through the release of dividend equivalent rights.

Lemaitre Vascular Inc. reports the release of dividend equivalent rights, resulting in the acquisition of common stock by an insider.

A Lemaitre Vascular Inc. executive acquired shares through the release of dividend equivalent rights associated with a restricted stock unit award.

Lemaitre Vascular Inc. has reported the release of dividend equivalent rights and the subsequent acquisition of common stock on a one-for-one basis.

Lawrence J. Jasinski, an executive at Lemaitre Vascular Inc., acquired shares through the release of dividend equivalent rights.